The overall goal of this proposal is to determine the dynamics of virus replication and T cell turnover in HIV-1 infected infants and children. The long-term objective is to determine the impact of combination antiviral drug therapy on T cell regeneration by thymus-dependent and thymus-independent pathways and on the cell reservoir responsible for maintaining covert virus infection. Recent studies from our laboratory show that we can achieve prolonged, durable suppression of viral replication and a reversal of T cell abnormalities and T cell regeneration by thymus dependent mechanisms. Despite suppression of viral replication below the limit of detection, virus persists within infected cells in transcriptionally active but non-productive and latent states. Our objectives are to systematically define the molecular events necessary for establishing and maintaining the initial and subsequent cellular reservoir, the dynamics of replication and cell turnover in each of the relevant tissue compartments, and the state of the viral genome within the infected cell population. We hypothesize that higher numbers of activated target cells, trafficking of early progenitor cells from the thymus, and a developing immature immune system are likely to account for complex differences in the dynamics of plasma virus and infected cell population turnover between children and adults. The potential importance of infection of specific cell populations, through altered virus replication dynamics and cell turnover, provide rationale and motives for studies of viral gene expression, viral latency, and the genetic composition of virus in vivo in virus particles, in defined cell types, and in cellular collections. We will study both infants and children, seeking to determine any age-dependant changes in the thymic renewal mechanisms, and age-related differences in the duration of infection, antiviral drug experience, and control of viral replication after combination antiviral drug therapy. From such data, detailed mathematical analyses similar to those performed on samples from adults can be done that provide a kinetic picture of the mechanisms of compensatory reactivity and expansion of the T cell population and virus production, and into their capacity to respond to antiviral drug therapy. These investigations will provide fundamental insights into the pathogenesis of pediatric HIV-1 infection, and help establish theoretical principles to guide the rationale approach to the development of efficacious treatment strategies.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD037356-03
Application #
6363427
Study Section
Special Emphasis Panel (ZRG5-AARR-2 (01))
Program Officer
Nugent, Robert
Project Start
1999-03-01
Project End
2004-02-29
Budget Start
2001-03-01
Budget End
2002-02-28
Support Year
3
Fiscal Year
2001
Total Cost
$490,411
Indirect Cost
Name
Northwestern University at Chicago
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Ching, Natascha; Nielsen-Saines, Karin A; Deville, Jaime G et al. (2010) Autologous neutralizing antibody to human immunodeficiency virus-1 and replication-competent virus recovered from CD4+ T-cell reservoirs in pediatric HIV-1-infected patients on HAART. AIDS Res Hum Retroviruses 26:585-91
Ching, Natascha; Deville, Jaime G; Nielsen, Karin A et al. (2007) Cellular and humoral immune responses to a tetanus toxoid booster in perinatally HIV-1-infected children and adolescents receiving highly active antiretroviral therapy (HAART). Eur J Pediatr 166:51-6
Badran, Bassam M; Kunstman, Kevin; Stanton, Jennifer et al. (2005) Transcriptional regulation of the human CD3 gamma gene: the TATA-less CD3 gamma promoter functions via an initiator and contiguous Sp-binding elements. J Immunol 174:6238-49
Hirsch, Vanessa M; Santra, Sampa; Goldstein, Simoy et al. (2004) Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques. J Virol 78:275-84
Wolinsky, Steven M; Veazey, Ronald S; Kunstman, Kevin J et al. (2004) Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses. Virology 328:19-29
Kuhmann, Shawn E; Pugach, Pavel; Kunstman, Kevin J et al. (2004) Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor. J Virol 78:2790-807
Pope, Melissa; Haase, Ashley T (2003) Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med 9:847-52
Trachtenberg, Elizabeth; Korber, Bette; Sollars, Cristina et al. (2003) Advantage of rare HLA supertype in HIV disease progression. Nat Med 9:928-35
Kunstman, Kevin J; Puffer, Bridget; Korber, Bette T et al. (2003) Structure and function of CC-chemokine receptor 5 homologues derived from representative primate species and subspecies of the taxonomic suborders Prosimii and Anthropoidea. J Virol 77:12310-8
Badran, Bassam M; Wolinsky, Steven M; Burny, Arsene et al. (2002) Identification of three NFAT binding motifs in the 5'-upstream region of the human CD3gamma gene that differentially bind NFATc1, NFATc2, and NF-kappa B p50. J Biol Chem 277:47136-48

Showing the most recent 10 out of 15 publications